BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

635 related articles for article (PubMed ID: 9862720)

  • 1. Intrinsic defects in macrophage IL-12 production associated with immune dysfunction in the MRL/++ and New Zealand Black/White F1 lupus-prone mice and the Leishmania major-susceptible BALB/c strain.
    Alleva DG; Kaser SB; Beller DI
    J Immunol; 1998 Dec; 161(12):6878-84. PubMed ID: 9862720
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aberrant cytokine expression and autocrine regulation characterize macrophages from young MRL+/+ and NZB/W F1 lupus-prone mice.
    Alleva DG; Kaser SB; Beller DI
    J Immunol; 1997 Dec; 159(11):5610-9. PubMed ID: 9548504
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SJL and NOD macrophages are uniquely characterized by genetically programmed, elevated expression of the IL-12(p40) gene, suggesting a conserved pathway for the induction of organ-specific autoimmunity.
    Alleva DG; Johnson EB; Wilson J; Beller DI; Conlon PJ
    J Leukoc Biol; 2001 Mar; 69(3):440-8. PubMed ID: 11261792
    [TBL] [Abstract][Full Text] [Related]  

  • 4. T cell cytokine imbalance towards production of IFN-gamma and IL-10 in NZB/W F1 lupus-prone mice is associated with autoantibody levels and nephritis.
    Enghard P; Langnickel D; Riemekasten G
    Scand J Rheumatol; 2006; 35(3):209-16. PubMed ID: 16766368
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Macrophages from lupus-prone MRL mice are characterized by abnormalities in Rho activity, cytoskeletal organization, and adhesiveness to extracellular matrix proteins.
    Longacre A; Koh JS; Hsiao KK; Gilligan H; Fan H; Patel VA; Levine JS
    J Leukoc Biol; 2004 Nov; 76(5):971-84. PubMed ID: 15316033
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aberrant regulation of IL-1 expression in macrophages from young autoimmune-prone mice.
    Donnelly RP; Levine J; Hartwell DQ; Frendl G; Fenton MJ; Beller DI
    J Immunol; 1990 Nov; 145(10):3231-9. PubMed ID: 2230116
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adhesion elicits an intrinsic defect in interleukin-1 expression by macrophages from autoimmune-prone MRL mice.
    Levine JS; Koh JS; Hartwell D; Beller DI
    J Autoimmun; 1998 Apr; 11(2):141-50. PubMed ID: 9650093
    [TBL] [Abstract][Full Text] [Related]  

  • 8. T helper 1 response against Leishmania major in pregnant C57BL/6 mice increases implantation failure and fetal resorptions. Correlation with increased IFN-gamma and TNF and reduced IL-10 production by placental cells.
    Krishnan L; Guilbert LJ; Wegmann TG; Belosevic M; Mosmann TR
    J Immunol; 1996 Jan; 156(2):653-62. PubMed ID: 8543817
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [TH1 response in the experimental infection with Trypanosoma cruzi].
    Cardoni RL; Antúnez MI; Abrami AA
    Medicina (B Aires); 1999; 59 Suppl 2():84-90. PubMed ID: 10668248
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prostaglandin E2-mediated dysregulation of proinflammatory cytokine production in pristane-induced lupus mice.
    Chae BS; Shin TY; Kim DK; Eun JS; Leem JY; Yang JH
    Arch Pharm Res; 2008 Apr; 31(4):503-10. PubMed ID: 18449509
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pregnancy impairs resistance of C57BL/6 mice to Leishmania major infection and causes decreased antigen-specific IFN-gamma response and increased production of T helper 2 cytokines.
    Krishnan L; Guilbert LJ; Russell AS; Wegmann TG; Mosmann TR; Belosevic M
    J Immunol; 1996 Jan; 156(2):644-52. PubMed ID: 8543816
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Underproduction of interleukin-12 in susceptible mice during progressive leishmaniasis is due to decreased CD40 activity.
    Heinzel FP; Rerko RM; Hujer AM
    Cell Immunol; 1998 Mar; 184(2):129-42. PubMed ID: 9630839
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The involvement of neutrophils in the resistance to Leishmania major infection in susceptible but not in resistant mice.
    Chen L; Zhang ZH; Watanabe T; Yamashita T; Kobayakawa T; Kaneko A; Fujiwara H; Sendo F
    Parasitol Int; 2005 Jun; 54(2):109-18. PubMed ID: 15866472
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early IL-4 production does not predict susceptibility to Leishmania major.
    Scott P; Eaton A; Gause WC; di Zhou X; Hondowicz B
    Exp Parasitol; 1996 Nov; 84(2):178-87. PubMed ID: 8932767
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Leishmania major: a clone with low virulence for BALB/c mice elicits a Th1 type response and protects against infection with a highly virulent clone.
    Li J; Nolan TJ; Farrell JP
    Exp Parasitol; 1997 Sep; 87(1):47-57. PubMed ID: 9287957
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Leishmania major: differential resistance to infection in C57BL/6 (high interferon-alpha/beta) and congenic B6.C-H-28c (low interferon-alpha/beta) mice.
    Shankar AH; Morin P; Titus RG
    Exp Parasitol; 1996 Nov; 84(2):136-43. PubMed ID: 8932763
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Defective macrophage function in neonates and its impact on unresponsiveness of neonates to polysaccharide antigens.
    Chelvarajan RL; Collins SM; Doubinskaia IE; Goes S; Van Willigen J; Flanagan D; De Villiers WJ; Bryson JS; Bondada S
    J Leukoc Biol; 2004 Jun; 75(6):982-94. PubMed ID: 14982942
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Susceptibility to Leishmania major infection in mice: multiple loci and heterogeneity of immunopathological phenotypes.
    Lipoldová M; Svobodová M; Krulová M; Havelková H; Badalová J; Nohýnková E; Holán V; Hart AA; Volf P; Demant P
    Genes Immun; 2000 Feb; 1(3):200-6. PubMed ID: 11196712
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Leishmania major: targeting IL-4 in successful immunomodulation of murine infection.
    Wakil AE; Wang ZE; Locksley RM
    Exp Parasitol; 1996 Nov; 84(2):214-22. PubMed ID: 8932771
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Imbalance towards Th1 predominance is associated with acceleration of lupus-like autoimmune syndrome in MRL mice.
    Takahashi S; Fossati L; Iwamoto M; Merino R; Motta R; Kobayakawa T; Izui S
    J Clin Invest; 1996 Apr; 97(7):1597-604. PubMed ID: 8601623
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.